RELATIONSHIP OF THYROID-STIMULATING HORMONE WITH METABOLIC SYNDROME IN A SAMPLE OF EUTHYROID PAKISTANI POPULATION
AbstractBackground: Metabolic Syndrome is a group of factors that predispose to cardiovascular diseases.The prevalence of metabolic syndrome is rising rapidly. Recently, a few studies have suggested thatlower thyroid function in the reference range may be associated with metabolic syndrome, but theissue remains unsettled. We aimed to elucidate the relationship between thyroid function andcomponents of metabolic syndrome in a sample of euthyroid Pakistani population. Methods: Thisanalytical, cross-sectional study was conducted at the Department of Physiology, University ofHealth Sciences, Lahore, Pakistan, and extended over a period of 12 months. It included 100 subjectswith metabolic syndrome in the study group and thirty subjects without metabolic syndrome in thecontrol group with age ranging 45–55 years. Both groups had normal thyroid function. After adetailed history and clinical examination, fasting blood was analysed for glucose, triglycerides, highdensity lipoprotein-cholesterol along with thyroid-stimulating hormone (TSH) and free thyroxine.Results: Serum TSH was significantly higher in study group than in control group (p=0.040). Serumfree thyroxine values of study group were slightly but not significantly lower than those of controlgroup. Serum TSH correlated significantly and positively with serum triglycerides in all subjects andwith waist circumference and diastolic blood pressure in men. Serum TSH showed a positive andlinear relationship with the number of components of metabolic syndrome (p=0.016) in all subjects.Conclusion: High-normal TSH is associated with metabolic syndrome and its components. Theremay be increased risk of cardiovascular diseases with high-normal TSH levels.Keywords: Thyroid Stimulating Hormone, Metabolic Syndrome, Euthyroid
Dysmetabolic syndrome X; Metabolic syndrome; code 277.7;
[cited 27th July 2009] Available from:
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel HR,
Franklin BA et al. Diagnosis and management of the metabolic
syndrome: an American heart association/ national heart, lung and
blood institute scientific statement: executive summary. Circ
Grundy SM. Metabolic syndrome pandemic. Arterioscler Thromb
Vasc Biol 2008;28:629.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic
syndrome among US adults: findings from the third national
health and nutrition examination survey. JAMA2002;287:356–9.
Basit A, Shera AS. Prevalence of metabolic syndrome in Pakistan.
Metabolic Syndrome and Related Disorders 2008;6(3):171–5.
Surana SP, Shah DB, Gala K, Susheja S, Hoskote SS, Gill N et al.
Prevalence of metabolic syndrome in an urban Indian diabetic
population using the NCEP ATP III guidelines. Journal of
Association of Physicians of India 2008;56:865–8.
Mehboob F, Majeed MZ, Zaman SM. An impact of lifestyle and
obesity on diabetes, hypertension and hyperlipidemia. J Fatima
Jinnah Med Coll Lahore 2007;1:59–63.
Bonow RO, Eckel RH. Diet, obesity, and cardiovascular risk. N
Engl J Med 2003;348:2057–8.
Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the
developing world -a growing challenge. N Engl J Med
McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven
G. Use of metabolic markers to identify overweight individuals
who are insulin resistant. Ann Intern Med 2003;139:802–9.
Reaven G. Metabolic syndrome: pathophysiology and implications
for management of cardiovascular disease. Circulation
Groop L. Genetics of the metabolic syndrome. British Journal of
Nutrition 2000;83, Suppl.1:S39–48.
Roche HM, Phillips C, Gibney MJ. The metabolic syndrome: the
crossroads of diet and genetics. Proceedings of the Nutrition
Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M, et
al. Cardiovascular morbidity and mortality associated with the
metabolic syndrome. Diabetes Care 2001;24:683–9.
Reddy KS. Cardiovascular disease in non-western countries. N
Eng J Med 2004;350:2438–40.
Krotkiewski M. Thyroid hormones in the pathogenesis and
treatment of obesity. European Journal of Pharmacology
Fommei E, Iervasi G. The role of thyroid hormone in blood
pressure homeostasis: evidence from short-term hypothyroidism in
humans. J Clin Endocrinol Metab 2002;87:1996–2000.
Roos A, Bakker SJL, Links TP, Gans ROB and Wolffenbuttel
BHR. Thyroid function is associated with components of the
metabolic syndrome in euthyroid subjects. J Clin Endocrinol
Asvold BO, Vatten LJ, Nilsen TIL, Bjoro T. The association
between TSH within the reference range and serum lipid
concentrations in a population based study, The HUNT study.
European Journal of Endocrinology 2007;156:181–6.
Knudsen N, Laurberg P, Rasmussen LB, Bulow I, Perrild H,
Ovesene L, et al. Small differences in thyroid function may be
important for body mass index and the occurrence of obesity in the
population. J Clin Endocrinol Metab 2005;90:4019–24.
Park HT, Cho GJ, Ahn KH, Shin JH, Hong SC, Kim T, et al.
Thyroid stimulating hormone is associated with metabolic
syndrome in euthyroid post menopausal women. Maturitas
Shantha GPS, Kumar AA, Jeyachandran V, Rajamanickam D,
Rajkumar K, Salim S, et al. Association between primary
hypothyroidism and metabolic syndrome and the role of C reactive
protein: a cross-sectional study from South India. Thyroid
Ortho Clinical Diagnostics [homepage on the internet]; Vitros®
immunodiagnostic products; FT4 and TSH reagent packs:
instructions for use [cited Jan 21, 2008]; Available from:
Fernandez-Real JM, Lopez-Bermejo A, Castro A, Casamitjana R,
Ricart W. Thyroid function is intrinsically linked to insulin
sensitivity and endothelium-dependent vasodilation in healthy
euthyroid subjects. J Clin Endocrinol Metab 2006;91:3337–43.
J Ayub Med Coll Abbottabad 2011;23(2)
Kim BJ, Kim TY, Koh JM, Kim HK, Park JY, Lee KU, et al.
Relationship between serum free T4 (FT4) levels and metabolic
syndrome (MS) and its components in healthy euthyroid subjects.
Clinical Endocrinology 2009;70:152–60.
Lin SY, Wang YY, Liu PH, Lai WA, Sheu WH-H. Lower serum
free thyroxine levels are associated with metabolic syndrome in a
Chinese population. Metabolism: clinical and experimental
Asvold BO, Bjoro T, Nilsen TIL, Gunnell D, Vatten LJ.
Thyrotropin levels and risk of fatal coronary heart disease. Arch
Intern Med 2008;168:855–60.
Goichot B, Sapin R, Schlienger JL. Subclinical hyperthyroidism:
considerations in defining the lower limit of the thyrotropin
reference interval. Clinical Chemistry 2009;55:420–4.
Al-Adsani H, Hoffer LJ, Silva JE. Resting energy expenditure is
sensitive to small dose changes in patients on chronic thyroid
hormone replacement. J Clin Endocrinol Metab 1997;82:1118–25.
Torrance CJ, Devente JE, Jones JP, Dohm GL. Effects of thyroid
hormone on GLUT 4 glucose transporter gene expression and
NIDDM in rats. Endocrinology 1997;138:1204–14.
Boelen A, Schiphorst MCP-T, Wiersinga WM. Soluble cytokine
receptors and the low 3,5,3'-triiodothyronine syndrome in patients
with non-thyroidal disease. J Clin Endocrinol Metab 1995;80:971–6.
Asvold BO, Bjoro T, Nilsen TIL, Vatten LJ. Tobacco smoking and
thyroid function. Arch Intern Med 2007;167:1428–32.
Sari R, Balci MK, Altunbas H, Karayalcin U. The effect of body
weight and weight loss on thyroid volume and function in obese
women. Clinical Endocrinology 2003;59:258–62.
Brent GA. The molecular basis of thyroid hormone action. N Eng
J Med 1994;331:847–53.
Kim SR, Talbott EA, Tull E, Vogt M, Andersen S, Kuller LH.
Contribution of abnormalities of thyroid hormones to type 2
diabetes. Diabetes Care 2000;23:260–1.